Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delta agent hepatitis.

M Chatzinoff1, L S Friedman

  • 1Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania.

Infectious Disease Clinics of North America
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: avoiding corticosteroids in the treatment of inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2017
Same author

Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras.

Leukemia·2016
Same author

The association between U.S. Poison Center assistance and length of stay and hospital charges.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

The role of donor-specific HLA alloantibodies in liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.

Oncogene·2013
Same author

Commentary: low-volume bowel preparation for colonoscopy.

Alimentary pharmacology & therapeutics·2012
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

The delta agent, a unique RNA pathogen dependent on HBV, causes severe hepatitis. Prevention through hepatitis B vaccination is crucial as no effective treatment exists.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • The delta agent (HDV) is a novel RNA pathogen discovered a decade ago.
  • HDV is exclusively dependent on the hepatitis B virus (HBV) for replication.
  • It suppresses hepatitis B synthesis and causes severe liver disease.

Purpose of the Study:

  • To characterize the delta agent and its clinical significance.
  • To identify populations at risk for delta infection.
  • To outline strategies for preventing HDV infection.

Main Methods:

  • Literature review and characterization of HDV properties.
  • Identification of risk factors and transmission routes.
  • Analysis of clinical outcomes associated with HDV infection.

Related Experiment Videos

Main Results:

  • HDV is a significant global cause of fulminant hepatitis and progressive liver disease.
  • High-risk groups include individuals in endemic areas and specific patient populations (drug abusers, hemophiliacs, hemodialysis patients, homosexual men).
  • Widespread dissemination of HDV is a potential concern.

Conclusions:

  • There is no effective treatment for established delta infections.
  • Prevention of HDV infection relies on robust hepatitis B vaccination strategies.
  • Public health efforts should focus on preventing HBV infection to curb HDV spread.